Oramed Pharmaceuticals (ORMP) Change in Account Payables (2010 - 2024)
Oramed Pharmaceuticals (ORMP) posted Change in Account Payables of $1.5 million for Q3 2024, down 30.16% on a QoQ basis from $2.2 million in Q2 2024, and down 10.42% year-over-year from $1.7 million in Q4 2023.
Oramed Pharmaceuticals (ORMP) Change in Account Payables (2010 - 2024) Analysis & Trends
Oramed Pharmaceuticals' Change in Account Payables history runs 13 years deep, the most recent figure standing at $1.5 million for Q3 2024.
- Quarterly Change in Account Payables fell 10.42% year-over-year to $1.5 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $2.5 million (up 651.79% YoY) and the FY2023 annual result came in at -$2.2 million, down 491.76% from the prior year.
- Change in Account Payables was $1.5 million for Q3 2024 at Oramed Pharmaceuticals, down from $2.2 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.2 million in Q2 2024 and bottomed at -$3.2 million in Q2 2023.
- A 3-year average of $174727.3 and a median of $389000.0 in 2020 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 322.83% in 2020, while the deepest fall reached 1009.82% in 2020.
- Oramed Pharmaceuticals' Change in Account Payables stood at $1.2 million in 2020, then tumbled by 154.12% to -$624000.0 in 2023, then soared by 347.92% to $1.5 million in 2024.
- Business Quant data shows ORMP's Change in Account Payables at $1.5 million in Q3 2024, $2.2 million in Q2 2024, and -$666000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.55 Mn |
| Sep 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 2.22 Mn |
| Jun 30, 2024 | 2.22 Mn |
| Mar 31, 2024 | -666,000.00 |
| Mar 31, 2024 | -666,000.00 |
| Dec 31, 2023 | -624,000.00 |
| Dec 31, 2023 | -624,000.00 |
| Sep 30, 2023 | 1.73 Mn |
| Sep 30, 2023 | 1.73 Mn |
| Jun 30, 2023 | -3.23 Mn |
| Jun 30, 2023 | -3.23 Mn |
| Mar 31, 2023 | -103,000.00 |
| Mar 31, 2023 | -103,000.00 |
| Nov 30, 2020 | 1.15 Mn |
| Nov 30, 2020 | 1.15 Mn |
| Aug 31, 2020 | 389,000.00 |
| Aug 31, 2020 | 389,000.00 |
| May 31, 2020 | -1.02 Mn |
| May 31, 2020 | -1.02 Mn |